Yarrow Bioscience Inc (YARW)

US · Healthcare · Biotechnology

$30.58+17.89%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$97,000

Revenue YoY

+40.6%

Net profit

$-3.0M

EPS

$-2.14

Net margin

-3,100.0%

Market cap

$75.9M

Forward P/E

0.0

P/B

0.00

52-week high

$44.28

52-week low

$8.22

50-day MA

$36.26

200-day MA

$30.99

Beta

2.07

with an average price target of $57.00.

Insiders

7.12%

Institutions

66.69%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Yarrow Bioscience Inc — free to start.

Data updated 2026-09-18.